JOURNAL OF CANCER RESEARCH AND ONCOBIOLOGY
Robert J. Amato
Department: Department of Internal Medicine
University: The University of Texas Health Science Center
Country: United States
Robert J. Amato is a Professor in the Department of Internal Medicine and Director of the Division of Oncology at McGovern Medical School, The University of Texas Health Science Center at Houston, and the Memorial Hermann Cancer Center.
He received his D.O. from The University of North Texas in Fort Worth, Texas, in 1983. He serves as an editorial board member and reviewer for numerous journals and has had more than 300 publications over the course of his career.
Dr. Amato is one of the world’s leading experts in the treatment of genitourinary cancer. Early in his career, his research helped make testicular cancer a highly treatable disease. His current clinical research focuses on molecular-targeted therapeutics to halt the progression of metastatic kidney and prostate cancers, the further development of immunotherapies with a primary focus on vaccine and immune therapy, and the development of more effective treatments for bladder cancer. He is also involved in a number of translational research projects seeking insight into the molecular alterations associated with disease progression and resistance adaptation, as well as biomarker discovery.
His research interests focuses on Tumor Immunology, Molecular Targeted Therapy, Genitourinary Oncology, Personalized Therapy, Circulating Tumor Cells, Biomarker Discovery, Next-Generation Sequencing.
Open Access Journals
Subscribe to our Newsletter
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: firstname.lastname@example.org
Recently Released Issues
Copyright © 2020 Boffin Access Limited.